Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04453072 · ClinicalTrials.gov registry record · NA

A Study to See if an iPhone Weight Management App Can Help Promote Weight Loss in Adolescents and Young Adults After a Stem Cell Transplant

A NA study of Obesity and Malignant Neoplasm, sponsored by Jonsson Comprehensive Cancer Center.

Recruiting
Registry status
NA
Development phase
20
Enrollment target
1
Study location

NCT04453072: Recruiting NA study of Obesity and Malignant Neoplasm, sponsored by Jonsson Comprehensive Cancer Center.

NCT04453072 is a NA study of Obesity and Malignant Neoplasm that is actively recruiting participants, run by Jonsson Comprehensive Cancer Center. The registered enrollment target is 20 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04453072, a NA study of Obesity and Malignant Neoplasm, is actively recruiting participants, sponsored by Jonsson Comprehensive Cancer Center.

RECRUITING
Registry status
NA
Development phase
20 participants
Enrollment target
1
Study location

Study Summary

This early phase I trial studies how well a behavioral weight loss intervention consisting of a smartphone application and coaching works for the promotion of weight loss in adolescents and young adults after a stem cell transplant. This study may help researchers learn more about how adolescents and young adults can lose weight and develop healthy eating habits.

Primary Outcome

The main outcomes measures will be height (meters), weight (kg), and BMI (kg/m\^2). Height will be measured to assess consistency in height measurements. Weight will be measured to assess trends in weight over the time span of the intervention. BMI will be measured as a product of weight and height to obtain an appropriate metric that accounts for these measures, and is the standard measure to assess weight progression in weight intervention studies.

Interventions

  • OTHER Questionnaire Administration
  • OTHER Interview
  • OTHER Media Intervention
  • BEHAVIORAL Telephone-Based Intervention
  • OTHER Scale Device

Study Locations (1)

California

  • UCLA / Jonsson Comprehensive Cancer Center - Los Angeles

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2020-07-01
Est. Completion 2026-12-31
Phase NA
Jonsson Comprehensive Cancer Center

321 total trials

What NCT04453072 shows while recruiting

NCT04453072 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (98% lower).

The record links to 2 conditions, with Obesity appearing as the primary indexed condition, and to 5 interventions - of which Questionnaire Administration is the first listed.

NCT04453072 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT04453072 about?

NCT04453072 is a clinical study titled "A Study to See if an iPhone Weight Management App Can Help Promote Weight Loss in Adolescents and Young Adults After a Stem Cell Transplant". This early phase I trial studies how well a behavioral weight loss intervention consisting of a smartphone application and coaching works for the promotion of weight loss in adolescents and young adults after a stem cell transplant. This study may help researchers learn more about how adolescents an...

What is the current status of trial NCT04453072?

This trial is currently recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2020-07-01. Estimated completion is 2026-12-31.

What conditions does trial NCT04453072 study?

This clinical trial studies the following conditions: Obesity, Malignant Neoplasm.

What interventions are being tested in trial NCT04453072?

The interventions under investigation include: Questionnaire Administration (OTHER), Interview (OTHER), Media Intervention (OTHER), Telephone-Based Intervention (BEHAVIORAL), Scale Device (OTHER).

Who is sponsoring clinical trial NCT04453072?

This trial is sponsored by Jonsson Comprehensive Cancer Center, which has 321 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04453072 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04453072's enrollment target sits among peer trials

20 946th of 1053 higher than 80 of 1,053 other Obesity trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00573339 · 20 participants

    Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing

  • NCT00692939 · 20 participants · Phase 1

    Autologous Stem Cell Transplantation for Crohn's Disease

  • NCT00967785 · 20 participants · Phase 1

    A Phase I Study of Mozobil in the Treatment of Patients With WHIMS

  • NCT01406691 · 20 participants · Phase 4

    Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04453072, the US trial registry maintained by the National Library of Medicine. NCT04453072 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.